Latest

PACIFIC BASIN (02343.HK): Executive director Helt to step down ] On 26 October 2026, PACIFIC BASIN (02343.HK) said Kristian Helt will step down as executive director on 21 November 2026, remaining head of chartering.
17:59
PACIFIC BASIN02343.HKBoard Change
HENGRUI PHARMA (01276.HK): Three drugs win clinical trial approval ] On 26 October 2026, HENGRUI PHARMA (01276.HK) won a clinical trial approval for SHR-2005 with SHR-1501, with or without adebrelimab, in bladder cancer.
17:53
HENGRUI PHARMA01276.HKR&D Progress
LEPU BIO (02157.HK): CMG901 Phase III meets primary endpoint, 3L gastric cancer OS 10.0 vs 5.0 months ] On October 26, 2026, LEPU BIO (02157.HK) reported ESMO data showing CMG901's Phase III trial met its primary endpoint, with median OS of 10.0 versus 5.0 months in third-line or later CLDN18.2-positive gastroesophageal cancer.
17:50
LEPU BIO02157.HKADC overseas
HUTCHMED (00013.HK): Orpathys plus Tagrisso cuts progression risk 44% in first-line EGFR-mutant lung cancer ] On October 26, 2026, HUTCHMED (00013.HK) reported SANOVO Phase III data showing ORPATHYS® plus TAGRISSO® extended median PFS to 24.9 months versus 13.8 months in first-line EGFR-mutant, MET-overexpressed NSCLC, cutting progression risk 44%.
17:48
HUTCHMED00013.HKoverseas
NEW GONOW RV (00805.HK) shareholding highly concentrated: 22 holders and chairman own 90.38% ] On October 26, 2026, the SFC said 22 shareholders and related parties of NEW GONOW RV (00805.HK) held 41.69% and chairman Miao Xuezhong 48.69%, taking the combined stake to 90.38%.
17:45
NEW GONOW RV00805.HKShareholding Concentration
TENNOR THERAP-B (06872.HK): Plans H share buyback of up to RMB 50 mln ] On 26 October 2026, TENNOR THERAP-B (06872.HK) proposed an H share buyback of up to 5,232,892 shares, or 10% of issued H shares, for up to RMB 50 million.
17:43
TENNOR THERAP-B06872.HKBuyback
GLORY SUN LAND (00299.HK): receives delisting decision, last trading day set for November 6 ] On October 26, 2026, GLORY SUN LAND (00299.HK) said the Listing Committee decided to cancel its listing under Rule 6.01A(1); absent a review, the last trading day is November 6 and delisting takes effect on November 9.
17:42
GLORY SUN LAND00299.HKDelisting
YUE YUEN IND (00551.HK) issues profit warning: 9M profit attributable to owners seen down 50%-55% ] On October 26, 2026, YUE YUEN IND (00551.HK) issued a profit warning, expecting nine-month profit attributable to owners to fall about 50%-55% from US$278.7 million a year earlier, with manufacturing revenue down 3.8%.
17:41
YUE YUEN IND00551.HKProfit Warning
CH AGRI-PROD EX (00149.HK): Issues HKD 20 mln 2038 notes ] On 26 October 2026, CH AGRI-PROD EX (00149.HK) issued HKD 20 million of 2038 notes under its HKD 1 billion medium term note programme, due 26 October 2038.
17:37
CH AGRI-PROD EX00149.HKNote Issue
ELIFE HLDGS (00223.HK): Completes placing of 277.52 mln shares ] On 26 October 2026, ELIFE HLDGS (00223.HK) completed a placing of 277,520,000 shares at HKD 0.1 each, raising net proceeds of about HKD 27.20 million.
17:33
ELIFE HLDGS00223.HKPlacing
Hong Kong Recently Listed Stocks Daily Report: BAIGE DIGITAL Leads with 27.81% Gain as Consumer and Medical Technology Stocks Strengthen - 20261026 ] On October 26, 2026, BAIGE DIGITAL rose 27.81% to top the gainers; MINIMAX-W led on liquidity with turnover of HKD 3.051 billion; MABWELL-B and XIZHI TECH-P will see lock-up releases this week.
17:12
Hong Kong Recently Listed Stocks Daily ReportBAIGE DIGITALHEALTHYWAY INCCAMSENSE
HK shares ETFs Daily Report: Dividend and High-Yield Themes Lead as Technology Growth Pulls Back — October 26, 2026 ] On October 26, 2026, defensive themes prevailed in the Hong Kong ETF market. E Fund (HK) CSI Liquor Index ETF (03189.HK) rose 2.32% to lead, with dividend and high-yield products advancing collectively and four of them in the top ten, while technology growth names pulled back, led by Bosera SZSE ChiNext Daily (2x) Leveraged Product (07234.HK) down 4.06%; nine of the top ten decliners were technology-related.
16:40
HK Shares ETFs Daily ReportE Fund (HK) CSI Liquor Index ETFBosera Szse Chinext Daily (2x) Leveraged Product
Offshore Trust Insight | MARKETINGFORCE (02556.HK) First-Half Revenue Up 111.2% YoY, Subsidiary Grants Loan of Up to RMB 300 Million to Controlling Shareholder ] MARKETINGFORCE (02556.HK) closed at HKD 48.96 on October 23, 2026, up 8.18%. Founder Zhao Xulong has established a founder family trust as settlor, with THE CORE TRUST COMPANY LIMITED as trustee.
16:23
MARKETINGFORCE02556.HKOffshore Trust
Offshore Trust Insight | BUTONG GROUP (06090.HK) closes down 0.78%; Wang Wei controls about 46.6% of interests through a Singapore family trust ] BUTONG GROUP (06090.HK) listed on the Main Board of the Hong Kong Stock Exchange on 23 September 2025 at a final offer price of HKD 71.20. Founder Wang Wei established the Boyan Family Trust and serves as its settlor and protector, while co-founder Shen Ling established the Shen Ling Family Trust and serves as its settlor and protector; the trustee of both trusts is Vistra Trust (Singapore) Pte. Limited of Singapore. The company was included in the Hang Seng Composite Index and added to the Stock Connect eligible securities lists on 9 March 2026.
16:21
Butong Group06090.HKOffshore Trust
HK Stock Connect Insight | HBM HOLDINGS-B (02142.HK): Batoclimab approved in China; southbound stake rises to 13.24% since Stock Connect entry on Sept 7 ] On Oct 23, HBM Holdings-B (02142.HK) announced that batoclimab injection (Enlida) has been approved by China's NMPA for generalized myasthenia gravis, the company's first approved product, on which it retains tiered royalties in Greater China. Included in the Stock Connect on Sept 7, its southbound stake rose from 2.10% on the first effective day to 13.24% on Oct 23, or 119.81 million shares worth about HK$1.23 billion.
15:31
HBM HOLDINGS-B02142.HKHK Stock Connect Insight
HK Stock Connect Insight | WENGE AI (01956.HK) First-Half Newly Signed Contract Value of About RMB 355 Million, Down 34.26% Since Stock Connect Inclusion ] WENGE AI (01956.HK) closed at HKD 59.10 on October 23, 2026, down 4.98% for the day. The company's shares were included in the Hang Seng Composite Index with effect from September 7, 2026 and were accordingly added to Stock Connect, and the share price has fallen about 34.26% since inclusion.
15:15
WENGE AI01956.HKHK Stock Connect
Autonomous Driving Concept Stocks Insight | XPENG-W (09868.HK) Traded Lower, XPeng Obtained Approval for Citywide L4 Robotaxi Demonstration Operation in Guangzhou ] On October 26, 2026, XPENG-W (09868.HK) weakened. As of 14:00, it was quoted at HK$35.78, down 3.61%.
14:12
XPENG-W09868.HKAutonomous Driving
ALPHAMAB-B (09966.HK): JSKN033 cervical cancer Phase I/II data at ESMO 2026, ORR 41.9% ] On October 26, 2026, ALPHAMAB-B (09966.HK) announced that Phase I/II results of JSKN033 in cervical cancer after failure of standard treatment were presented at the 2026 ESMO Congress, with an ORR of 41.9% and a median PFS of 7.0 months.
13:43
ALPHAMAB-B09966.HKNewTimeSpace
iShares Asia ex-Japan(03010.HK) up 0.74%, SK hynix returns due Wed ] As of 13:30 HKT, Oct 26, 2026, iShares Asia ex-Japan(03010.HK) rose 0.74% to HK$82.100; tracking MSCI AC Asia ex Japan, it holds HK$30.55bn, board lot 100.
13:42
iShares Asia ex-Japan03010.HKETF Intraday Move
ALPHAMAB-B (09966.HK): Anbenitamab Phase III data at ESMO 2026, first-line breast cancer risk cut 54% ] On October 26, 2026, ALPHAMAB-B (09966.HK) announced that Phase III results of Anbenitamab (KN026) in first-line HER2+ breast cancer and second-line or later HER2+ gastric cancer were presented at the 2026 ESMO Congress as LBA oral presentations.
13:37
ALPHAMAB-B09966.HKoverseas
Previous1..1314 151617..607     607 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments